Literature DB >> 18608910

Persistent pulmonary infection with an azole-resistant Coccidioides species.

John D Kriesel1, Deanna A Sutton, Susan Schulman, Annette W Fothergill, Michael G Rinaldi.   

Abstract

We report a case of a life-threatening, recurrent, and azole-resistant pulmonary coccidioidomycosis in a patient receiving long-term fluconazole therapy for a history of coccidioidal meningitis. Since this diagnosis, the patient has received weekly amphotericin B for more than four years and remains in remission with a stable serum Coccidioides complement fixation antibody titer.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18608910     DOI： 10.1080/13693780802140923

Source DB:  PubMed          Journal:  Med Mycol        ISSN： 1369-3786            Impact factor:   4.076


  7 in total

1.  Coccidioides thyroiditis in an HIV-infected patient.

Authors:  Sadao Jinno; Shelley Chang; Michael R Jacobs
Journal:  J Clin Microbiol       Date:  2012-04-18       Impact factor: 5.948

2.  Call for a California coccidioidomycosis consortium to face the top ten challenges posed by a recalcitrant regional disease.

Authors:  George R Thompson; David A Stevens; Karl V Clemons; Josh Fierer; Royce H Johnson; Jane Sykes; George Rutherford; Michael Peterson; John W Taylor; Vishnu Chaturvedi
Journal:  Mycopathologia       Date:  2014-10-16       Impact factor: 2.574

3.  The Orotomide Olorofim Is Efficacious in an Experimental Model of Central Nervous System Coccidioidomycosis.

Authors:  Nathan P Wiederhold; Laura K Najvar; Rosie Jaramillo; Marcos Olivo; Michael Birch; Derek Law; John H Rex; Gabriel Catano; Thomas F Patterson
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

4.  Antifungal therapeutics for dimorphic fungal pathogens.

Authors:  Kristie D Goughenour; Chad A Rappleye
Journal:  Virulence       Date:  2016-09-19       Impact factor: 5.882

5.  Large-Scale Evaluation of In Vitro Amphotericin B, Triazole, and Echinocandin Activity against Coccidioides Species from U.S. Institutions.

Authors:  George R Thompson; Bridget M Barker; Nathan P Wiederhold
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

6.  Synthesis and antifungal activity in vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum.

Authors:  Rossana de Aguiar Cordeiro; Francisca Jakelyne de Farias Marques; Rebecca de Aguiar Cordeiro; Marcos Reinaldo da Silva; Angela Donato Maia Malaquias; Charlline Vládia Silva de Melo; Jair Mafezoli; Maria da Conceição Ferreira de Oliveira; Raimunda Sâmia Nogueira Brilhante; Marcos Fábio Gadelha Rocha; Tereza de Jesus Pinheiro Gomes Bandeira; José Júlio Costa Sidrim
Journal:  Antimicrob Agents Chemother       Date:  2014-02-10       Impact factor: 5.191

Review 7.  Therapies and Vaccines Based on Nanoparticles for the Treatment of Systemic Fungal Infections.

Authors:  Brenda Kischkel; Suélen A Rossi; Samuel R Santos; Joshua D Nosanchuk; Luiz R Travassos; Carlos P Taborda
Journal:  Front Cell Infect Microbiol       Date:  2020-09-03       Impact factor: 5.293
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.